跳至主要内容
临床试验/NCT07750717
NCT07750717尚未招募不适用

Correlation Between Tidal Volume in Spontaneous Ventilation and Tidal Volume in Non-invasive Ventilation in Acute Hypoxemic Non-hypercapnic Respiratory Failure

Centre Hospitalier Departemental Vendee1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年9月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
试验地点
1
主要终点
Show a correlation between the tidal volume measurement in spontaneous ventilation and the tidal volume measurement in NIV

研究概览

简要总结

The diagnosis of Acute Respiratory Distress Syndrome (ARDS) is a syndromic diagnosis that groups together patients who may have very different prognoses and respond differently to the same therapies.

Additionally, non-invasive ventilation (NIV) has shown highly contrasting results in the early management of ARDS. One of the predictive criteria for NIV failure is an excessively high tidal volume during non-invasive ventilation.

SPIRALI is a pilot study evaluating the relevance of a respiratory physiology parameter, the tidal volume relative to the theoretical ideal body weigh, in the phenotypic classification of non-intubated ARDS patients. In this initial approach, the investigators will compare the tidal volume during high-flow oxygen therapy with the tidal volume obtained under NIV (after applying a settings optimization algorithm). The investigators hypothesize that if tidal volume is linked to each situation, the same patients will exhibit a high tidal volume both during spontaneous ventilation and under NIV.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient over 18 years of age;
  • Patient hospitalized in intensive care for less than 24 hours;
  • Patient with severe hypoxemic acute respiratory failure characterized by a PaO2/FiO2 ratio < 300 mmHg and > 150 mmHg under high-flow oxygen therapy at 60 L/min;
  • Patient able to cooperate with the spirometry test;
  • Patient able to follow the protocol and having given their informed written consent to participate in the study;
  • Patient affiliated with the social security system or entitled to benefits;

排除标准

  • Patients with an indication for intubation;
  • Patients with a contraindication for or who refuse NIV;
  • Patients with hemodynamic instability requiring vasopressor support greater than 0.25 μg/kg/min of norepinephrine;
  • Patients with a Glasgow score < 15;
  • Patients with hypercapnia (PaCO2 > 45 mmHg);
  • Patients with a PaO2/FiO2 ratio < 150 mmHg;
  • Patients with cardiogenic pulmonary edema;
  • Patients who have already undergone a session of NIV in intensive care during this stay;
  • Patients with chronic respiratory failure (home oxygen therapy or home non-invasive ventilation (excluding indications solely for sleep apnea syndrome));
  • Patients who have recently had a pneumothorax;
  • Patients who have recently undergone eye surgery (e.g., cataract surgery) or throat surgery;
  • Patients with significant arterial disease: recent heart attack, pulmonary embolism, poorly controlled hypertension despite treatment, etc.
  • Patients already included in the study;
  • Pregnant women, women in labor, or women who are breastfeeding;
  • Patients under guardianship, conservatorship, or deprived of their liberty;
  • Patients under an activated future protection mandate;
  • Patients under family authorization;
  • Patients under judicial protection;

研究组 & 干预措施

tidal volume in spontaneous ventilation and NIV

Experimental

干预措施: Hand-held spirometer (Device)

tidal volume in spontaneous ventilation and NIV

Experimental

干预措施: NIV (Device)

结局指标

主要结局

Show a correlation between the tidal volume measurement in spontaneous ventilation and the tidal volume measurement in NIV

时间窗: At T2 and T3, with measurement of VT using a portable spirometer and NIV on the day of enrollment. T1,T2,T3<1h30min

Tidal volume measured by a hand-held spirometer in spontaneous ventilation and exhaled tidal volume measured by the ventilator in NIV after optimization of the settings

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验